Tandem Diabetes Care Stock Forecast
NASDAQ: TNDMHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 9, 1:55 PM ET
TNDM analyst consensus
Consensus (25 analysts)
buy
Avg. price target
$27.86+77.85%
- Strong buy 3
- Buy 11
- Hold 11
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 25 Wall Street analysts covering Tandem Diabetes Care (2026-10-08), 14 rate the stock a buy or strong buy, 11 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $27.86, with a high estimate of $50.00 and a low estimate of $18.00. The average target implies upside of 77.8% from the current price of $15.67.
The spread between the highest and lowest targets is 177.8%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for TNDM.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 12% |
| Buy | 11 | 44% |
| Hold | 11 | 44% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $18.00 | +14.91% |
| Average target | $27.86 | +77.85% |
| High target | $50.00 | +219.18% |